Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1961;23:749-753

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VÉREL, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VÉREL, D.

(Circulation. 1961;23:749.)
© 1961 American Heart Association, Inc.


Blood Volume Changes in Cyanotic Congenital Heart Disease and Polycythemia Rubra Vera

DAVID VÉREL M.D.1

1 From the Regional Cardiovascular Unit, City General Hospital, Sheffield, England.

The blood volume has been measured in 12 adult patients with cyanotic congenital heart disease and in 12 patients with polycythemia rubra vera by radioactive isotopes. In congenital heart disease the total blood volume was found to be within normal limits provided the red cell volume had not risen so high as to make an increase in total blood volume inevitable. In polycythemia rubra vera the total blood volume increased rapidly once a hematocrit level of 55 per cent had been exceeded. Increasing polycythemia in congenital heart disease was found to be associated with the predictable fall in plasma volume, and a formula for estimating the plasma volume from the predicted normal blood volume and the hematocrit is presented. It is suggested that the low plasma volume that may be found in very polycythemic patients may be partly responsible for their known tendency to postoperative hemorrhage.




This article has been cited by other articles:


Home page
BloodHome page
J. L. Spivak and R. T. Silver
The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal
Blood, July 15, 2008; 112(2): 231 - 239.
[Full Text] [PDF]


Home page
BloodHome page
J. L. Spivak
Polycythemia vera: myths, mechanisms, and management
Blood, December 15, 2002; 100(13): 4272 - 4290.
[Full Text] [PDF]